Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Keyhole surgery for stomach cancer: faster recovery or not?

NCT ID NCT02248519

Disease control Sponsor: UMC Utrecht Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compared two types of surgery for stomach cancer: laparoscopic (keyhole) and open surgery. The goal was to see if keyhole surgery leads to a shorter hospital stay and fewer complications. The trial included 210 patients with resectable stomach cancer and is now complete.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
surgery (laparoscopic or open gastrectomy)
What this could lead to
If laparoscopic gastrectomy proves better, it could become the standard, less invasive surgical option for gastric cancer patients, leading to faster recovery and fewer complications.
What could go wrong
This is a completed trial with 210 patients, but results may not apply to all gastric cancer types or populations. Laparoscopic surgery may not be feasible in all cases and could require conversion to open surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

210 people

The number who actually took part.

Started

Dec 2014

Finished

Dec 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Histologically proven adenocarcinoma of the stomach * Surgically resectable (cT1-4a, N0-3b, M0) tumor * Age ≥ 18 years * European Clinical Oncology Group (ECOG) performance status 0, 1 or 2. * Written informed consent Exclusion Criteria: * Siewert type I esophagogastric junction tumor * Non-elective surgery * Previous gastric resection or recurrent gastric cancer * Pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gastric adenocarcinoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

gastric adenocarcinoma gastric cancer gastric neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gastric cancer

Contacts and locations

Locations

  • Academic Medical Center

    Amsterdam, 1105 AZ, Netherlands

  • Catharina Hospital

    Eindhoven, 5623 EJ, Netherlands

  • Erasmus Medical Center

    Rotterdam, 3015 CE, Netherlands

  • Gelre Hospital

    Apeldoorn, Netherlands

  • Leiden University Medical Center

    Leiden, 2333 ZA, Netherlands

  • Meander Medical Center

    Amersfoort, Netherlands

  • University Medical Center Utrecht

    Utrecht, 3584 CX, Netherlands

  • VU University Medical Center

    Amsterdam, 1081 HZ, Netherlands

  • Zorggroep Twente Almelo

    Almelo, Netherlands

  • Zuyderland Medical Center

    Sittard-Geleen, 6162 BG, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.